StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30573% above fair value
$220.83−0.89 (-0.40%)

Close on Nov 2, 2026Market cap $88.16BP/E –Yield –

Moderna AstraZeneca collaboration revenue by Quarter

AstraZeneca collaboration revenue ($M) ($M)

QuarterlyAnnual

Moderna AstraZeneca collaboration revenue: $0M in Q4 2023. That is the lowest of the 17 quarters on record here. No newer figure appears in the documents we track.

Latest, Q4 2023
0
Period ended Dec 31, 2023
Change on a year earlier
–
0 in Q4 2022
History
17 quarters
Since Q2 2019
Sources
13
Documents cited below

Where the Q4 2023 figure comes from

Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)

Source: Form 10-K (filed 2025-02-21) ↗

Reported in Form 10-Q / 10-K Collaboration Agreements Note.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAstraZeneca collaboration revenue ($M) ($M)Year on yearSource
Q4 2023Dec 31, 20230–Form 10-K (filed 2025-02-21) ↗
Q3 2023Sep 30, 20230-100.0%Form 10-Q (filed 2023-11-03) ↗
Q2 2023Jun 30, 20230-100.0%Form 10-Q (filed 2023-08-03) ↗
Q4 2022Dec 31, 20220–Form 10-K (filed 2025-02-21) ↗
Q3 2022Sep 30, 202276+2,433.3%Form 10-Q (filed 2023-11-03) ↗
Q2 2022Jun 30, 202240.0%Form 10-Q (filed 2023-08-03) ↗
Q4 2021Dec 31, 20210-100.0%Form 10-K (filed 2024-02-23) ↗
Q3 2021Sep 30, 20213–Form 10-Q (filed 2022-11-03) ↗
Q2 2021Jun 30, 20214-75.0%Form 10-Q (filed 2022-08-03) ↗
Q1 2021Mar 31, 20210-100.0%Form 10-Q (filed 2021-05-06) ↗
Q4 2020Dec 31, 202016+5,233.3%Form 10-K (filed 2023-02-24) ↗
Q3 2020Sep 30, 20200-100.0%Form 10-Q (filed 2021-11-04) ↗
Q2 2020Jun 30, 202016+7,900.0%Form 10-Q (filed 2021-08-05) ↗
Q1 2020Mar 31, 20201–Form 10-Q (filed 2021-05-06) ↗
Q4 2019Dec 31, 20190.30–Form 10-K (filed 2022-02-25) ↗
Q3 2019Sep 30, 20193.70–Form 10-Q (filed 2020-10-30) ↗

Cite this data

StockData. (2026). Moderna AstraZeneca collaboration revenue ($M), quarterly Q2 2019–Q4 2023 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/rev-collab-az

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.